Patents by Inventor Richard S. Rogers

Richard S. Rogers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICROPOROUS POLYOLEFIN MEMBRANES FROM BESPOKE SOLVENTS
    Publication number: 20240139689
    Abstract: Halogen-free, microporous polyolefin membranes are disclosed herein. The halogen-free, microporous polyolefin membranes can be manufactured using an environmentally friendly manufacturing process that includes extrusion of polymer-plasticizer mixtures followed by sheet formation and extraction of the plasticizer with a halogen-free solvent. The halogen-free solvent has a flashpoint greater than about 23° C. and an initial boiling point at least about 50° C. lower than the flashpoint of the plasticizer. The process can further be a closed loop process in which the halogen-free solvent can be reused.
    Type: Application
    Filed: January 9, 2024
    Publication date: May 2, 2024
    Inventors: Weston J. Wood, Don Spitz, Matthew Alan Warren, Cory S. Rogers, Richard W. Pekala
  • Antibody therapies for human immunodeficiency virus (HIV)
    Patent number: 11845788
    Abstract: Featured are PGT121 variant antibodies or fragments thereof, which can be administered, e.g., as antibody therapies for treating human immunodeficiency virus (HIV) infection. In particular, featured are methods of treating subjects infected with HIV and/or blocking HIV infections in subjects at risk of HIV transmission using the PGT121 variant antibodies or fragments thereof.
    Type: Grant
    Filed: May 22, 2019
    Date of Patent: December 19, 2023
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Dan H. Barouch, Bruce A. Kerwin, Randal R. Ketchem, Alison J. Gillespie, Christine C. Siska, Rutilio H. Clark, Julee A. Floyd, Jeremy M. Shaver, Richard S. Rogers
  • ANTIBODY THERAPIES FOR HUMAN IMMUNODEFICIENCY VIRUS (HIV)
    Publication number: 20210206838
    Abstract: Featured are PGT121 variant antibodies or fragments thereof, which can be administered, e.g., as antibody therapies for treating human immunodeficiency virus (HIV) infection. In particular, featured are methods of treating subjects infected with HIV and/or blocking HIV infections in subjects at risk of HIV transmission using the PGT121 variant antibodies or fragments thereof.
    Type: Application
    Filed: May 22, 2019
    Publication date: July 8, 2021
    Inventors: Dan H. BAROUCH, Bruce A. KERWIN, Randal R. KETCHEM, Alison J. GILLESPIE, Christine C. SISKA, Rutilio H. CLARK, Julee A. FLOYD, Jeremy M. SHAVER, Richard S. ROGERS
  • HIGH THROUGHPUT ANTIBODY VARIANT SCREENING METHOD
    Publication number: 20190346456
    Abstract: Disclosed is a high throughput method for selecting an antibody variant amino acid sequence of interest from a plurality of antibody variant amino acid sequences. The method is particularly useful in the engineering of improved antibodies.
    Type: Application
    Filed: May 12, 2019
    Publication date: November 14, 2019
    Applicant: Just Therapeutics, Inc.
    Inventors: Rutilio H. Clark, Richard S. Rogers